{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:32:51Z","timestamp":1793766771073,"version":"4.6.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"DOI":"10.1186\/s13011-025-00675-5","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:22:25Z","timestamp":1759314145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Barriers to opioid replacement therapy in pregnant women with opioid use disorder: a systematic review"],"prefix":"10.1186","volume":"20","author":[{"given":"Biruk Adie","family":"Admass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belete Muluadam","family":"Admassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wubie Birlie","family":"Chekol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eniyew Assimie","family":"Alemu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debas Yaregal","family":"Melesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas Admasu","family":"Ferede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demelash Gedefaye","family":"Anteneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulualem Endeshaw","family":"Zeleke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samrawit Andargie","family":"Kassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abebe Chanie","family":"Wagaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon Yimer","family":"Nigatu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natnael Atnafu","family":"Gebeyehu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"11","key":"675_CR1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1080\/00048670903270449","volume":"43","author":"R Durrant","year":"2009","unstructured":"Durrant R, Adamson S, Todd F, Sellman D. Drug use and addiction: evolutionary perspective. Australian New Z J Psychiatry. 2009;43(11):1049\u201356.","journal-title":"Australian New Z J Psychiatry"},{"issue":"1","key":"675_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7517-2-8","volume":"2","author":"T Saah","year":"2005","unstructured":"Saah T. The evolutionary origins and significance of drug addiction. Harm Reduct J. 2005;2(1):1\u20137.","journal-title":"Harm Reduct J"},{"key":"675_CR3","doi-asserted-by":"crossref","unstructured":"Mathers C, Fat D, Boerma J. The global burden of disease: 2004 update: World Health Organization; 2008. Geneva, Switzerland. 2020.","DOI":"10.1186\/s13690-020-00458-3"},{"key":"675_CR4","volume-title":"Statistical manual of mental disorders: DSM-5","author":"A Diagnostic","year":"2013","unstructured":"Diagnostic A. Statistical manual of mental disorders: DSM-5. (ed.) Washington. DC: American Psychiatric Association; 2013."},{"issue":"1","key":"675_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","volume":"6","author":"J Strang","year":"2020","unstructured":"Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, et al. Opioid use disorder. Nat Reviews Disease Primers. 2020;6(1):3.","journal-title":"Nat Reviews Disease Primers"},{"key":"675_CR6","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.ejim.2019.10.019","volume":"70","author":"C Mattiuzzi","year":"2019","unstructured":"Mattiuzzi C, Lippi G. Worldwide epidemiology of alcohol and drugs abuse. Eur J Intern Med. 2019;70:e27\u20138.","journal-title":"Eur J Intern Med"},{"issue":"12","key":"675_CR7","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Global Health. 2017;5(12):e1192\u2013207.","journal-title":"Lancet Global Health"},{"issue":"1","key":"675_CR8","first-page":"E55","volume":"3","author":"SD Turner","year":"2015","unstructured":"Turner SD, Gomes T, Camacho X, Yao Z, Guttmann A, Mamdani MM, et al. Neonatal opioid withdrawal and antenatal opioid prescribing. Can Med Association Open Access J. 2015;3(1):E55\u201361.","journal-title":"Can Med Association Open Access J"},{"issue":"1","key":"675_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/OGX.0000000000001094","volume":"78","author":"KS Ryan","year":"2023","unstructured":"Ryan KS, Prewitt KC, Hayer S, Hedges MA, Benson AE, Lo JO. Opioid use in pregnancy: a review. Obstet Gynecol Surv. 2023;78(1):35\u201349.","journal-title":"Obstet Gynecol Surv"},{"issue":"013","key":"675_CR10","first-page":"55","volume":"2","author":"S Abuse","year":"2013","unstructured":"Abuse S. Mental health services administration. Results the. 2013;2(013):55\u201368.","journal-title":"Results the"},{"key":"675_CR11","doi-asserted-by":"crossref","unstructured":"Haight SC. Opioid use disorder documented at delivery hospitalization\u2014United States, 1999\u20132014. MMWR Morbidity and mortality weekly report. 2018;67.","DOI":"10.15585\/mmwr.mm6731a1"},{"key":"675_CR12","doi-asserted-by":"crossref","unstructured":"Patrick SW, Barfield WD, Poindexter BB, Cummings J, Hand I, Adams-Chapman I et al. Neonatal opioid withdrawal syndrome. Pediatrics. 2020;146(5).","DOI":"10.1542\/peds.2020-029074"},{"issue":"1","key":"675_CR13","first-page":"906723","volume":"2014","author":"VE Whiteman","year":"2014","unstructured":"Whiteman VE, Salemi JL, Mogos MF, Cain MA, Aliyu MH, Salihu HM. Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the united States. J Pregnancy. 2014;2014(1):906723.","journal-title":"J Pregnancy"},{"issue":"7","key":"675_CR14","doi-asserted-by":"publisher","first-page":"e208256","DOI":"10.1001\/jamanetworkopen.2020.8256","volume":"3","author":"DJ Corsi","year":"2020","unstructured":"Corsi DJ, Hsu H, Fell DB, Wen SW, Walker M. Association of maternal opioid use in pregnancy with adverse perinatal outcomes in ontario, canada, from 2012 to 2018. JAMA Netw Open. 2020;3(7):e208256\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"675_CR15","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","volume":"121","author":"A Maeda","year":"2014","unstructured":"Maeda A, Bateman BT, Clancy CR, Creanga AA, Leffert LR. Opioid abuse and dependence during pregnancy: Temporal trends and obstetrical outcomes. Anesthesiology. 2014;121(6):1158\u201365.","journal-title":"Anesthesiology"},{"key":"675_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.earlhumdev.2018.10.010","volume":"128","author":"LN Bakhireva","year":"2019","unstructured":"Bakhireva LN, Holbrook BD, Shrestha S, Leyva Y, Ashley M, Cano S, et al. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5\u20138 months of age. Early Hum Dev. 2019;128:69\u201376.","journal-title":"Early Hum Dev"},{"issue":"9","key":"675_CR17","doi-asserted-by":"publisher","first-page":"19142","DOI":"10.2807\/ese.14.09.19142-en","volume":"14","author":"V Gyarmathy","year":"2009","unstructured":"Gyarmathy V, Giraudon I, Hedrich D, Montanari L, Guarita B, Wiessing L. Drug use and pregnancy\u2013challenges for public health. Eurosurveillance. 2009;14(9):19142.","journal-title":"Eurosurveillance"},{"issue":"3","key":"675_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/ACO.0000000000000590","volume":"31","author":"BL Raymond","year":"2018","unstructured":"Raymond BL, Kook BT, Richardson MG. The opioid epidemic and pregnancy: implications for anesthetic care. Curr Opin Anesthesiology. 2018;31(3):243\u201350.","journal-title":"Curr Opin Anesthesiology"},{"key":"675_CR19","doi-asserted-by":"crossref","unstructured":"Miele K. Medication for opioid use disorder during pregnancy\u2014maternal and infant network to understand outcomes associated with use of medication for opioid use disorder during pregnancy (MAT-LINK), 2014\u20132021. MMWR Surveillance Summaries. 2023;72.","DOI":"10.15585\/mmwr.ss7203a1"},{"issue":"7","key":"675_CR20","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/phar.1958","volume":"37","author":"TH Tran","year":"2017","unstructured":"Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ. Methadone, buprenorphine, and Naltrexone for the treatment of opioid use disorder in pregnant women. Pharmacotherapy: J Hum Pharmacol Drug Therapy. 2017;37(7):824\u201339.","journal-title":"Pharmacotherapy: J Hum Pharmacol Drug Therapy"},{"issue":"8","key":"675_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40263-015-0273-8","volume":"29","author":"CM Wilder","year":"2015","unstructured":"Wilder CM, Winhusen T. Pharmacological management of opioid use disorder in pregnant women. CNS Drugs. 2015;29(8):625\u201336.","journal-title":"CNS Drugs"},{"issue":"12","key":"675_CR22","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1111\/add.15582","volume":"116","author":"EE Krans","year":"2021","unstructured":"Krans EE, Kim JY, Chen Q, Rothenberger SD, James AE III, Kelley D, et al. Outcomes associated with the use of medications for opioid use disorder during pregnancy. Addiction (Abingdon England). 2021;116(12):3504\u201314.","journal-title":"Addiction (Abingdon England)"},{"key":"675_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2165\/11632820-000000000-00000","volume":"72","author":"HE Jones","year":"2012","unstructured":"Jones HE, Finnegan LP, Kaltenbach K. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs. 2012;72:747\u201357.","journal-title":"Drugs"},{"issue":"1","key":"675_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0889-8545(05)70362-4","volume":"25","author":"K Kaltenbach","year":"1998","unstructured":"Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy: effects and management. Obstet Gynecol Clin N Am. 1998;25(1):139\u201351.","journal-title":"Obstet Gynecol Clin N Am"},{"issue":"9","key":"675_CR25","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/j.1360-0443.2008.02283.x","volume":"103","author":"B Winklbaur","year":"2008","unstructured":"Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction. 2008;103(9):1429\u201340.","journal-title":"Addiction"},{"key":"675_CR26","doi-asserted-by":"crossref","unstructured":"Terplan M, Martin CE, Premkumar A, Krans EE. Caring for pregnant and parenting women with opioid use disorder. Treating opioid use disorder in general medical settings. Springer; 2021. pp. 203\u201321.","DOI":"10.1007\/978-3-030-80818-1_14"},{"key":"675_CR27","doi-asserted-by":"publisher","first-page":"100239","DOI":"10.1016\/j.dadr.2024.100239","volume":"11","author":"JK Bello","year":"2024","unstructured":"Bello JK, Dell NA, Laxton AM, Conte M, Chen L. Prevalence and predictors of medication for opioid use disorder among reproductive-aged women. Drug Alcohol Depend Rep. 2024;11:100239.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"4","key":"675_CR28","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ajog.2008.10.055","volume":"200","author":"AH Schempf","year":"2009","unstructured":"Schempf AH, Strobino DM. Drug use and limited prenatal care: an examination of responsible barriers. Am J Obstet Gynecol. 2009;200(4):412. e1-. e10.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"675_CR29","doi-asserted-by":"publisher","first-page":"100225","DOI":"10.1016\/j.ajogmf.2020.100225","volume":"2","author":"BS Bedrick","year":"2020","unstructured":"Bedrick BS, O\u2019Donnell C, Marx CM, Friedman H, Carter EB, Stout MJ, et al. Barriers to accessing opioid agonist therapy in pregnancy. Am J Obstet Gynecol MFM. 2020;2(4):100225.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"675_CR30","first-page":"174550572312241","volume":"20","author":"HB Apsley","year":"2024","unstructured":"Apsley HB, Brant K, Brothers S, Harrison E, Skogseth E, Schwartz RP, et al. Pregnancy-and parenting-related barriers to receiving medication for opioid use disorder: A multi-paneled qualitative study of women in treatment, women who terminated treatment, and the professionals who serve them. Women\u2019s Health. 2024;20:17455057231224181.","journal-title":"Women\u2019s Health"},{"key":"675_CR31","doi-asserted-by":"crossref","unstructured":"Chokshi R, Parish S, Santiago-Aponte N, Ural S, O\u2019Brien JM. Current research on opioid use disorder (OUD) in pregnancy with emphasis on medication assisted treatment (MAT). Med Res Archives. 2024;12(8).","DOI":"10.18103\/mra.v12i8.5736"},{"key":"675_CR32","doi-asserted-by":"crossref","unstructured":"El Helou N, Paul R, Valentine MC, Raghuraman N, Carter EB, Kelly JC et al. Reframing maternal opioid use disorder as an opportunity for delivering dyad-centered care: a call for action. Am J Obstet Gynecol MFM. 2022;4(4).","DOI":"10.1016\/j.ajogmf.2022.100646"},{"issue":"4","key":"675_CR33","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/dar.13421","volume":"41","author":"F Tsuda-McCaie","year":"2022","unstructured":"Tsuda-McCaie F, Kotera Y. A qualitative meta\u2010synthesis of pregnant women\u2019s experiences of accessing and receiving treatment for opioid use disorder. Drug Alcohol Rev. 2022;41(4):851\u201362.","journal-title":"Drug Alcohol Rev"},{"key":"675_CR34","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372.","DOI":"10.1136\/bmj.n71"},{"issue":"3","key":"675_CR35","first-page":"179","volume":"13","author":"C Lockwood","year":"2015","unstructured":"Lockwood C, Munn Z, Porritt K. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. JBI Evid Implement. 2015;13(3):179\u201387.","journal-title":"JBI Evid Implement"},{"issue":"3","key":"675_CR36","first-page":"132","volume":"13","author":"E Aromataris","year":"2015","unstructured":"Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. JBI Evid Implement. 2015;13(3):132\u201340.","journal-title":"JBI Evid Implement"},{"key":"675_CR37","unstructured":"Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Systematic reviews of prevalence and incidence. Joanna Briggs Institute reviewer\u2019s manual Adelaide, South Australia: The Joanna Briggs Institute. 2017;5:1\u20135."},{"issue":"8","key":"675_CR38","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s10896-022-00466-7","volume":"38","author":"PK Morrison","year":"2023","unstructured":"Morrison PK, Yourish E, Chang JC, Krans E, Pallatino-Trevelline C. Barriers to care for pregnant and post-partum women experiencing co-occurring intimate partner violence and opioid use disorder. J Family Violence. 2023;38(8):1625\u201337.","journal-title":"J Family Violence"},{"key":"675_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-021-03596-w","volume":"21","author":"C Leiner","year":"2021","unstructured":"Leiner C, Cody T, Mullins N, Ramage M, Ostrach BM. The elephant in the room; a qualitative study of perinatal fears in opioid use disorder treatment in Southern appalachia. BMC Pregnancy Childbirth. 2021;21:1\u201312.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"675_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/fampra\/cmab154","volume":"39","author":"J St. Louis","year":"2022","unstructured":"St. Louis J, Barreto T, Taylor M, Kane C, Worringer E, Eden AR. Barriers to care for perinatal patients with opioid use disorder: family physician perspectives. Fam Pract. 2022;39(2):249\u201356.","journal-title":"Fam Pract"},{"key":"675_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-021-06182-0","volume":"21","author":"D Titus-Glover","year":"2021","unstructured":"Titus-Glover D, Shaya FT, Welsh C, Qato DM, Shah S, Gresssler LE, et al. Opioid use disorder in pregnancy: leveraging provider perceptions to inform comprehensive treatment. BMC Health Serv Res. 2021;21:1\u201312.","journal-title":"BMC Health Serv Res"},{"issue":"15","key":"675_CR42","doi-asserted-by":"publisher","first-page":"9346","DOI":"10.3390\/ijerph19159346","volume":"19","author":"A Fiddian-Green","year":"2022","unstructured":"Fiddian-Green A, Gubrium A, Harrington C, Evans EA. Women-reported barriers and facilitators of continued engagement with medications for opioid use disorder. Int J Environ Res Public Health. 2022;19(15):9346.","journal-title":"Int J Environ Res Public Health"},{"key":"675_CR43","doi-asserted-by":"publisher","first-page":"108677","DOI":"10.1016\/j.drugalcdep.2021.108677","volume":"222","author":"JL Syvertsen","year":"2021","unstructured":"Syvertsen JL, Toneff H, Howard H, Spadola C, Madden D, Clapp J. Conceptualizing stigma in contexts of pregnancy and opioid misuse: a qualitative study with women and healthcare providers in Ohio. Drug Alcohol Depend. 2021;222:108677.","journal-title":"Drug Alcohol Depend"},{"key":"675_CR44","doi-asserted-by":"crossref","unstructured":"Odusi A, Hem-Lee-Forsyth SM, Viechweg ND, Estevez E. Intersectional disparities in opioid use disorder treatment: exploring barriers faced by pregnant African-American women. Univers Libr Med Health Sci. 2024;2(3).","DOI":"10.70315\/uloap.ulmhs.2024.0203002"},{"key":"675_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40352-015-0015-5","volume":"3","author":"R Stone","year":"2015","unstructured":"Stone R. Pregnant women and substance use: fear, stigma, and barriers to care. Health Justice. 2015;3:1\u201315.","journal-title":"Health Justice"},{"issue":"9","key":"675_CR46","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1177\/01939459231182495","volume":"45","author":"J Morton","year":"2023","unstructured":"Morton J, Vignato J, Anbari AB. Stigma experienced by perinatal women with opioid dependency in the united states: A qualitative meta-synthesis. West J Nurs Res. 2023;45(9):843\u201353.","journal-title":"West J Nurs Res"},{"issue":"4","key":"675_CR47","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/JPN.0000000000000587","volume":"36","author":"I Kantrowitz-Gordon","year":"2022","unstructured":"Kantrowitz-Gordon I, Price C, Rudolf V, Downey G, Castagnola K. Exploring perinatal nursing care for opioid use disorder: knowledge, stigma, and compassion. J Perinat Neonatal Nurs. 2022;36(4):353\u201361.","journal-title":"J Perinat Neonatal Nurs"},{"issue":"3","key":"675_CR48","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/ADM.0000000000001113","volume":"17","author":"DE Banks","year":"2023","unstructured":"Banks DE, Fentem A, Li X, Paschke M, Filiatreau L, Woolfolk C, et al. Attitudes toward medication for opioid use disorder among pregnant and postpartum women and people seeking treatment. J Addict Med. 2023;17(3):356\u20139.","journal-title":"J Addict Med"},{"key":"675_CR49","doi-asserted-by":"publisher","first-page":"108765","DOI":"10.1016\/j.jsat.2022.108765","volume":"139","author":"DM Schiff","year":"2022","unstructured":"Schiff DM, Work EC, Muftu S, Partridge S, MacMillan KDL, Gray JR, et al. You have to take this medication, but then you get punished for taking it: lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period. J Subst Abuse Treat. 2022;139:108765.","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"675_CR50","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.whi.2016.09.002","volume":"26","author":"C Angelotta","year":"2016","unstructured":"Angelotta C, Weiss CJ, Angelotta JW, Friedman RA. A moral or medical problem? The relationship between legal penalties and treatment practices for opioid use disorders in pregnant women. Women\u2019s Health Issues. 2016;26(6):595\u2013601.","journal-title":"Women\u2019s Health Issues"},{"key":"675_CR51","doi-asserted-by":"publisher","first-page":"688429","DOI":"10.3389\/fpsyg.2021.688429","volume":"12","author":"M Boeri","year":"2021","unstructured":"Boeri M, Lamonica AK, Turner JM, Parker A, Murphy G, Boccone C. Barriers and motivators to opioid treatment among suburban women who are pregnant and mothers in caregiver roles. Front Psychol. 2021;12:688429.","journal-title":"Front Psychol"},{"key":"675_CR52","doi-asserted-by":"publisher","first-page":"100453","DOI":"10.1016\/j.ssmqr.2024.100453","volume":"6","author":"C Sufrin","year":"2024","unstructured":"Sufrin C, Ziv T, Dayton L, Latkin C, Kramer C. They talked to me like I was dirt under their feet: treatment and withdrawal experiences of incarcerated pregnant people with opioid use disorder in four US States. SSM-Qualitative Res Health. 2024;6:100453.","journal-title":"SSM-Qualitative Res Health"},{"issue":"5","key":"675_CR53","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/add.16161","volume":"118","author":"KD Wagner","year":"2023","unstructured":"Wagner KD, Lee L. Commentary on rosen, et al.: attending to the unique needs of pregnant and parenting women at risk for overdose. Addiction (Abingdon England). 2023;118(5):855\u20136.","journal-title":"Addiction (Abingdon England)"},{"issue":"2","key":"675_CR54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/1533256X.2021.1903687","volume":"22","author":"L Curran","year":"2022","unstructured":"Curran L, Arthur-Jordan B, Rice J, Tan T. The risk of child removal by child protective services among pregnant women in medication-assisted treatment for opioid use disorder. J Social Work Pract Addictions. 2022;22(2):93\u2013107.","journal-title":"J Social Work Pract Addictions"},{"issue":"9","key":"675_CR55","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1080\/10826084.2023.2212074","volume":"58","author":"D Colson-Fearon","year":"2023","unstructured":"Colson-Fearon D, Antoine DG, Peirce JM, Kidorf M, Hammond AS. The impact of child protective services involvement on pregnant and postpartum women in substance use disorder treatment. Subst Use Misuse. 2023;58(9):1110\u20134.","journal-title":"Subst Use Misuse"},{"issue":"8","key":"675_CR56","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1111\/aogs.14850","volume":"103","author":"AW Kristensen","year":"2024","unstructured":"Kristensen AW, Vestermark V, Kj\u00e6rbye-Thygesen A, Eckhardt MC, Kesmodel US. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring. Acta Obstet Gynecol Scand. 2024;103(8):1522\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"675_CR57","first-page":"70","volume":"7","author":"CD Miller","year":"2017","unstructured":"Miller CD, Nizalik E, Grynspan D. Opioid replacement for pregnant mothers with opioid use disorder and fetal neurodevelopment: A review. Univ Ott J Med. 2017;7(2):70\u20134.","journal-title":"Univ Ott J Med"},{"issue":"3","key":"675_CR58","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3928\/02793695-20180219-03","volume":"56","author":"AL Haycraft","year":"2018","unstructured":"Haycraft AL. Pregnancy and the opioid epidemic. J PsychoSoc Nurs Ment Health Serv. 2018;56(3):19\u201323.","journal-title":"J PsychoSoc Nurs Ment Health Serv"},{"issue":"6","key":"675_CR59","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1080\/09540261.2021.1898350","volume":"33","author":"H Phillips","year":"2021","unstructured":"Phillips H, Lyon E, Krans EE, Warshaw C, Chang JC, Pallatino C. Barriers to help-seeking among intimate partner violence survivors with opioid use disorder. Int Rev Psychiatry. 2021;33(6):534\u201342.","journal-title":"Int Rev Psychiatry"},{"key":"675_CR60","first-page":"SART","volume":"9","author":"M Terplan","year":"2015","unstructured":"Terplan M, Kennedy-Hendricks A, Chisolm MS. Article commentary: prenatal substance use: exploring assumptions of maternal unfitness. Subst Abuse: Res Treat. 2015;9:SART.","journal-title":"Subst Abuse: Res Treat"},{"issue":"3","key":"675_CR61","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/08897077.2018.1488336","volume":"40","author":"SW Patrick","year":"2019","unstructured":"Patrick SW, Buntin MB, Martin PR, Scott TA, Dupont W, Richards M, et al. Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian States. Substance Abuse. 2019;40(3):356\u201362.","journal-title":"Substance Abuse"},{"issue":"1","key":"675_CR62","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/ADM.0000000000000826","volume":"16","author":"AC Lensch","year":"2022","unstructured":"Lensch AC, Hairston E, Carter G, Jones HE. Pregnant patients using opioids: treatment access barriers in the age of COVID-19. J Addict Med. 2022;16(1):e44\u20137.","journal-title":"J Addict Med"},{"key":"675_CR63","doi-asserted-by":"crossref","unstructured":"Bowser D, Bohler R, Davis MT, Hodgkin D, Horgan C. Payment-related barriers to medications for opioid use disorder: A critical review of the literature and real-world application. J Subst Use Addict Treat. 2024:209441.","DOI":"10.1016\/j.josat.2024.209441"},{"issue":"10","key":"675_CR64","doi-asserted-by":"publisher","first-page":"e2132103","DOI":"10.1001\/jamanetworkopen.2021.32103","volume":"4","author":"K Taylor","year":"2021","unstructured":"Taylor K, Compton S, Kolenic GE, Scott J, Becker N, Dalton VK, et al. Financial hardship among pregnant and postpartum women in the united states, 2013 to 2018. JAMA Netw Open. 2021;4(10):e2132103\u2013e.","journal-title":"JAMA Netw Open"},{"key":"675_CR65","doi-asserted-by":"publisher","first-page":"100064","DOI":"10.1016\/j.dadr.2022.100064","volume":"3","author":"C Guille","year":"2022","unstructured":"Guille C, Hall C, King C, Sujan A, Brady K, Newman R. Listening to women and pregnant and postpartum people: qualitative research to inform opioid use disorder treatment for pregnant and postpartum people. Drug Alcohol Depend Rep. 2022;3:100064.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"2","key":"675_CR66","doi-asserted-by":"publisher","first-page":"10868","DOI":"10.4081\/qrmh.2023.10868","volume":"7","author":"I Natale","year":"2023","unstructured":"Natale I, Harvey C, Wood P, Anderson K. It can save your life, that\u2019s all I know, barriers and facilitators for engagement in take-home Naloxone for people receiving opioid substitution treatment in regional australia: an explorative study. Qualitative Res Med Healthc. 2023;7(2):10868.","journal-title":"Qualitative Res Med Healthc"},{"issue":"1","key":"675_CR67","doi-asserted-by":"publisher","first-page":"e42417","DOI":"10.2196\/42417","volume":"12","author":"LA Wilson","year":"2023","unstructured":"Wilson LA, Gandhi P. Opioid agonist therapies and pregnancy outcomes for pregnant people with opioid use disorder: protocol for a systematic review. JMIR Res Protocols. 2023;12(1):e42417.","journal-title":"JMIR Res Protocols"},{"key":"675_CR68","doi-asserted-by":"publisher","first-page":"108855","DOI":"10.1016\/j.drugalcdep.2021.108855","volume":"226","author":"C Joshi","year":"2021","unstructured":"Joshi C, Skeer MR, Chui K, Neupane G, Koirala R, Stopka TJ. Women-centered drug treatment models for pregnant women with opioid use disorder: A scoping review. Drug Alcohol Depend. 2021;226:108855.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"675_CR69","first-page":"100","volume":"47","author":"J Kim","year":"2022","unstructured":"Kim J, Busse M, Kantrowitz-Gordon I, Altman MR. Health care experiences during pregnancy and parenting with an opioid use disorder. MCN: Am J Maternal\/Child Nurs. 2022;47(2):100\u20136.","journal-title":"MCN: Am J Maternal\/Child Nurs"},{"key":"675_CR70","doi-asserted-by":"crossref","unstructured":"Eggertson L. Stigma a major barrier to treatment for pregnant women with addictions. CMAJ; 2013.","DOI":"10.1503\/cmaj.109-4653"},{"issue":"13","key":"675_CR71","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1080\/10826084.2022.2115852","volume":"57","author":"C Joshi","year":"2022","unstructured":"Joshi C, Ho Chui KK, Skeer MR, Stopka TJ. Spatial and nonspatial factors associated with access to medication for opioid use disorder among pregnant women in Massachusetts. Subst Use Misuse. 2022;57(13):1904\u201317.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"675_CR72","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/10826084.2024.2421815","volume":"60","author":"O Olarewaju","year":"2025","unstructured":"Olarewaju O, Tundealao S. Pregnancy and the rising challenge of opioid dependency: A summary of potential solutions. Subst Use Misuse. 2025;60(2):306\u20139.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"675_CR73","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/ADM.0000000000000720","volume":"15","author":"JJ McCarthy","year":"2021","unstructured":"McCarthy JJ, Jones HE, Terplan M, Rudolf VP, von Klimo MC. Changing outdated methadone regulations that harm pregnant patients. J Addict Med. 2021;15(2):93\u20135.","journal-title":"J Addict Med"},{"key":"675_CR74","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s13669-016-0168-9","volume":"5","author":"KA Saia","year":"2016","unstructured":"Saia KA, Schiff D, Wachman EM, Mehta P, Vilkins A, Sia M, et al. Caring for pregnant women with opioid use disorder in the USA: expanding and improving treatment. Curr Obstet Gynecol Rep. 2016;5:257\u201363.","journal-title":"Curr Obstet Gynecol Rep"},{"issue":"1","key":"675_CR75","doi-asserted-by":"publisher","first-page":"100489","DOI":"10.1016\/j.ajogmf.2021.100489","volume":"4","author":"DJ Goodman","year":"2022","unstructured":"Goodman DJ, Saunders EC, Frew JR, Arsan C, Xie H, Bonasia KL, et al. Integrated vs nonintegrated treatment for perinatal opioid use disorder: retrospective cohort study. Am J Obstet Gynecol MFM. 2022;4(1):100489.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"3","key":"675_CR76","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/CXA.0000000000000216","volume":"15","author":"M Nader","year":"2024","unstructured":"Nader M, Hignell A, Lurie E, Schuler A, Sussman K, Turner S, et al. Outcome evaluation of an integrated, Combined-care perinatal addiction Medicine-Primary care obstetrics model for urban, Inner-city pregnant patients with severe substance use disorders. Can J Addict. 2024;15(3):29\u201339.","journal-title":"Can J Addict"},{"issue":"6","key":"675_CR77","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3109\/16066359.2010.545153","volume":"19","author":"K Milligan","year":"2011","unstructured":"Milligan K, Niccols A, Sword W, Thabane L, Henderson J, Smith A. Birth outcomes for infants born to women participating in integrated substance abuse treatment programs: A meta-analytic review. Addict Res Theory. 2011;19(6):542\u201355.","journal-title":"Addict Res Theory"},{"issue":"2","key":"675_CR78","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/ADM.0000000000001052","volume":"17","author":"LP Ellis","year":"2023","unstructured":"Ellis LP, Parlier-Ahmad AB, Scheikl M, Martin CE. An integrated care model for pregnant and postpartum individuals receiving medication for opioid use disorder. J Addict Med. 2023;17(2):131\u20139.","journal-title":"J Addict Med"},{"issue":"12","key":"675_CR79","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/MLR.0000000000000803","volume":"55","author":"MA Bachhuber","year":"2017","unstructured":"Bachhuber MA, Mehta PK, Faherty LJ, Saloner B. Medicaid coverage of methadone maintenance and the use of opioid agonist therapy among pregnant women in specialty treatment. Med Care. 2017;55(12):985\u201390.","journal-title":"Med Care"},{"issue":"3","key":"675_CR80","doi-asserted-by":"publisher","first-page":"100137","DOI":"10.1016\/j.ajogmf.2020.100137","volume":"2","author":"LJ Faherty","year":"2020","unstructured":"Faherty LJ, Stein BD, Terplan M. Consensus guidelines and state policies: the gap between principle and practice at the intersection of substance use and pregnancy. Am J Obstet Gynecol MFM. 2020;2(3):100137.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"675_CR81","doi-asserted-by":"crossref","unstructured":"Kameg BN. Modernizing perinatal substance use management. Policy Politics Nurs Pract. 2021;22(2):146\u201355.","DOI":"10.1177\/1527154420981945"},{"key":"675_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-020-01201-z","volume":"22","author":"AS Huhn","year":"2020","unstructured":"Huhn AS, Dunn KE. Challenges for women entering treatment for opioid use disorder. Curr Psychiatry Rep. 2020;22:1\u201310.","journal-title":"Curr Psychiatry Rep"},{"issue":"6","key":"675_CR83","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/09540261.2021.1908966","volume":"33","author":"DJ Hand","year":"2021","unstructured":"Hand DJ, Fischer AC, Gannon ML, McLaughlin KA, Short VL, Abatemarco DJ. Comprehensive and compassionate responses for opioid use disorder among pregnant and parenting women. Int Rev Psychiatry. 2021;33(6):514\u201327.","journal-title":"Int Rev Psychiatry"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-025-00675-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-025-00675-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-025-00675-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:09:18Z","timestamp":1759316958000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-025-00675-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["675"],"URL":"https:\/\/doi.org\/10.1186\/s13011-025-00675-5","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}